Net Loss -- Net loss was $13.6 million for the third quarter of 2025, compared to $16.4 million in Q3 2024. Ending Cash, Cash ...

GSK plc ( GSK) Q3 2025 Earnings Call October 29, 2025 8:00 AM EDT Ladies and gentlemen, a very warm welcome to the GSK Q3 2025 Results Call. I'm delighted to be joined today by Emma Walmsley, Luke ...

Merck & Eisai announce Welireg plus Lenvima meets primary endpoint of PFS in certain previously treated patients with advanced RCC: Rahway, New Jersey Wednesday, October 29, 2025, ...

Bone regeneration is the natural process by which new bone is formed to repair or replace damaged or lost bone tissue. This biological process involves ...

Biogen Inc. and Vanqua Bio today announced a license agreement granting Biogen exclusive worldwide rights to Vanqua's preclinical, oral C5aR1 antagonist. This agreement strengthens Biogen's immunology ...

In combination with pembrolizumab, for the first-line treatment of adult patients with advanced renal cell carcinoma (RCC). In combination with everolimus, for the treatment of adult patients with ...

Thermo Fisher Scientific Inc. ( NYSE: TMO) Q3 2025 Earnings Call October 22, 2025 8:30 AM EDT Good morning, ladies and gentlemen, and welcome to the Thermo Fisher Scientific 2025 Third Quarter ...

Formula 1 has long been more than a sport. For leading car manufacturers, it functions as a high-speed research and ...

Tradeweb Markets Inc. , a leading, global operator of electronic marketplaces for rates, credit, equities and money markets, today reported financial results for the quarter ended September 30, 2025.

A new study published in Nature Biotechnology shows that stem cell differentiation is linked to cellular structures called ...

Liver cells are indispensable for research—for drug testing, to better understand diseases such as hepatitis, fatty liver, cirrhosis, or liver cancer and for development of future cell therapies.